Out of 25 OECD countries for which data are available, the United States, Canada, Sweden, Norway, Ireland, England, and Wales experienced a rise in the average of opioid-related deaths (ORD) of more than 20% from 2011-2016. These findings are highlighted in the May 2019 OECD release: Addressing Problematic Opioid Use in OECD Countries, which calls for governments to take urgent action to combat the rise of ORD. In Canada,

Opioid-related deaths have been rising over recent years in North America and globally. New data released by the Public Health Agency of Canada reveals that more than 10,300 Canadians died as a result of an apparent opioid-related overdose between January 2016 and September 2018.

The current epidemic in the US is thought to have begun with the over-prescription of opioids for pain relief: in 1991, 76m opioid prescriptions were dispensed by US retail pharmacies. By 2011, this figure was 219m. The overall rate of death from drug overdose more than trebled in the US between 1999 and 2016.

U.S. surgeon general Jerome Adams in April 2018 urged employers to help in fighting the opioid epidemic. He was speaking at a conference sponsored by the National Business Group on Health (NBGH), an association of large employers. Adams estimates that 2.1 million people in the U.S. are struggling with an opioid-use condition. While these drugs can be helpful for a short time, they pose serious addiction risks. Common opioids include

Global insurance company XL Catlin issued their Q3 2017 October report, Emerging risks we’re watching and why, which highlights key factors in emerging risks presented by new state medical marijuana laws in the U.S. and the ongoing North American opioid epidemic. Of particular note is the marked reduction of the North American workforce as a result of the opioid epidemic. The Federal Reserve has cited the epidemic as one